NCT00974571View on ClinicalTrials.gov

Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,365

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

montelukast sodium

montelukast 10 mg tablet orally once daily at bedtime for 6 weeks

DRUG

Comparator: cetirizine

cetirizine 10 mg tablet orally once daily at bedtime for 6 weeks

DRUG

Comparator: placebo

placebo tablet orally once daily at bedtime for 6 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00974571 - Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246) | Biotech Hunter | Biotech Hunter